Showing results (11-20 of 49) with videos related to
Sort By:
Pageof 5
Journal of Radiation Research|May 17, 2014
Feasibility study of stereotactic body radiotherapy for peripheral lung tumors with a maximum dose of 100 Gy in five fractions and a heterogeneous dose distribution in the planning target volumeAtsuya Takeda, Yohei Oku, Naoko Sanuki, et al.Journal of Radiation Research|August 19, 2020
Comparison of prostate verification with implanted gold markers in tissue surrounding the prostate and pelvic bony anatomy for external beam radiation therapy following low-dose-rate brachytherapy: a prospective clinical trialTomoya Kaneda, Toshio Ohashi, Takashi Hanada, et al.Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|June 30, 2009
Molecular and epidemiological trend of rotavirus infection among infants and children in JapanShuvra Kanti Dey, Aksara Thongprachum, Yoshimi Ota, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Maximum standardized uptake value on FDG-PET is a strong predictor of overall and disease-free survival for non-small-cell lung cancer patients after stereotactic body radiotherapyAtsuya Takeda, Naoko Sanuki, Hirofumi Fujii, et al.International Journal of Radiation Oncology, Biology, Physics|January 14, 2014
Threshold doses for focal liver reaction after stereotactic ablative body radiation therapy for small hepatocellular carcinoma depend on liver function: evaluation on magnetic resonance imaging with Gd-EOB-DTPANaoko Sanuki, Atsuya Takeda, Yohei Oku, et al.Journal of Radiation Research|October 22, 2015
Stereotactic body radiotherapy for chronic obstructive pulmonary disease patients undergoing or eligible for long-term domiciliary oxygen therapyYu Hara, Atsuya Takeda, Takahisa Eriguchi, et al.Brachytherapy|September 5, 2016
Single-energy metal artifact reduction in postimplant computed tomography for I-125 prostate brachytherapy: Impact on seed identificationYutaka Shiraishi, Yoshitake Yamada, Tomoki Tanaka, et al.Cancer Medicine|March 27, 2018
Prostate-specific antigen nadir within 12 months as an early surrogate marker of biochemical failure and distant metastasis after low-dose-rate brachytherapy or external beam radiotherapy for localized prostate cancerShuichi Nishimura, Toshio Ohashi, Tetsuo Momma, et al.Journal of Medical Virology|July 4, 2007
Genetic heterogeneity, evolution, and recombination in norovirusesTung Gia Phan, Kunio Kaneshi, Yuichi Ueda, et al.International Journal of Clinical Oncology|October 31, 2013
Five-year potency preservation after iodine-125 prostate brachytherapyShuichi Nishimura, Atsunori Yorozu, Toshio Ohashi, et al.Pageof 5